{"entity":{"id":"nct04677816","kind":"trial","name":"Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients","aka":[],"tldr":"A phase 2 trial in triple-negative breast cancer, run by Wake Forest University Health Sciences, now recruiting.","summary":"Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients is a phase 2, interventional study registered as NCT04677816 by Wake Forest University Health Sciences, with a registry enrolment figure of 50 participants, started 2021-10-22 and due to reach its primary completion in 2026-12. Interventions recorded: Standard of Care Neoadjuvant Chemotherapy (NAC); Vitamin D3; Drug Diary. Conditions listed: Triple Negative Breast Cancer; Vitamin D Deficiency; Invasive Breast Cancer. Triple-negative eligibility wording from the registry: \"* Known triple negative ER/PR/HER2 receptor status as defined by:\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT04677816","url":"https://clinicaltrials.gov/study/NCT04677816"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04677816","phase":"2","setting":"Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients Receiving Neoadjuvant Chemotherapy for Operable Triple Negative Breast Cancer","sponsor":"Wake Forest University Health Sciences","enrolled":50,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04677816/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}